Some people with psoriasis go on to develop psoriatic arthritis, a condition that leads to itchy, sore patches on the skin in addition to joint pain. Treatment requires a coordinated effort by dermatologists and rheumatologists to help manage symptoms such as swelling, inflammation, and skin changes. At 91������ Langone’s Psoriatic Arthritis Center, we treat more than 1,300 people each year, giving them access to traditional and newer medications.

Our physicians and scientists are leading extensive research into providing the best care for patients with psoriatic arthritis, as well as studying the early events that may lead to developing the condition for insight into its origins. The center’s dermatologists, rheumatologists, and scientists use these discoveries to develop novel approaches to the diagnosis, treatment, and prevention of psoriatic arthritis.

We are also building upon recent discoveries made at 91������ Langone regarding the microbiome, which are the microbes that live in and on the human body, and new-onset rheumatoid arthritis. We are using these observations to shed light on the potential microbial triggers of psoriatic arthritis.

The Psoriatic Arthritis Center is involved in numerous clinical trials that evaluate treatments for the condition. We work with 91������ Langone’s Seligman Center for Advanced Therapeutics as well as the Psoriasis and Psoriatic Arthritis Research Registry, which tracks participants to answer important questions regarding psoriasis and psoriatic arthritis.